- Price
- $5.40
- Day
- +3.35%
- Mkt Cap
- $225.69M
- 52W Range
- $4.79 – $11.58
- Volume
- 390.9K
- Beta
- 0.99
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
GERMANTOWN, Md., July 21, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, August 6, 2026.
Read full article